|
|
 |
Vaccine
Information Statements
VISs by language
Hindi-language
VISs
Up-to-date
You
are encouraged to distribute the up-to-date English-language
VIS at the same
time as the translation.
Hindi-language
VISs
Out-of-date
The translations for some VISs on our website are from
previously published English-language versions that have
since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued.
Please ensure that your patients receive information
consistent with the current English-language version of
the following VISs.
You
are encouraged to distribute the up-to-date English-language
VIS at
the same time as the translation.
| |
|
These translations do not
contain the following CDC updates:
- Information was added about MMRV vaccine, tied to the
March 14 MMWR, regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR and
varicella vaccines given separately. Aside from two boxes containing
information about MMRV, both VISs are identical to the previous
editions.
- The new VISs should be used when MMRV is given; but the existing
stocks of the individual MMR and varicella VISs may be used when the
vaccines are given separately.
This translation does not contain the
following CDC updates:
- Section 1: The
answer has been rewritten by CDC.
- Section 2: There
are now 2 doses; the first dose is 12-15 months and the second
dose is 4-6 years.
- CDC added information
on MMRV.
- The URL for Vaccine
Adverse Event Reporting System (VAERS) has changed to www.vaers.hhs.gov.
- The URL for the
National Vaccine Injury Compensation Programs has changed
to www.hrsa.gov/vaccincompensation.
This translation does not contain the
following CDC updates:
- CDC changed the
indication to 1 year or older and has recommended routine
use for children.
- Section 2: Added
persons who work with primates or in research labs to indications
(routine vaccination).
- Added bullet
for "persons who live in communities that have prolonged
outbreaks of hepatitis A."
- Divided the section
into "Who" and "When" parts.
- Removed southern
Europe from list of regions with high rates of hepatitis
A.
- Section 3: Added
bullet about allergy to vaccine component.
- Changed wording,
particularly the statement on pregnancy, and made list into
bullets.
- Minor changes
to part 4, 5, and 6 to be consistent with other recent VISs.
- Removed the section
on immune globulin.
These translations do not contain the
following CDC updates:
- On July 18, the CDC posted an interim
VIS for hepatitis B. There are minor changes throughout, but the main
purpose of the update is to emphasize the birth dose for all children.
- A final version will be developed.
Thanks to
the Minnesota Department of Health and the California Department
of Health Services for their translations.This page was updated on
March 13, 2008 |
|
|
IAC Home